May 2023 in “Elsevier eBooks” The document's conclusion cannot be provided because the document is not readable or understandable.
November 2009 in “Eclética Química” The conclusion cannot be provided as the document content is not available.
3 citations
,
March 2017 in “Regulatory toxicology and pharmacology” Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.
November 2020 in “Journal of The American Academy of Dermatology” The conclusion is that many small genetic variations influence claw disorders in cows, and using genomic selection could help reduce these disorders.
April 2023 in “Journal of the American Academy of Dermatology” Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.
I'm sorry, but I cannot process the document as it is not in English. If you provide an English summary or conclusion, I can help summarize that for you.
November 2023 in “International Journal of Pharmaceutics” The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.
January 2008 in “Central South Pharmacy” A reliable method was developed to measure candesartan in human plasma.
November 1998 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not accessible.
September 1998 in “Hair transplant forum international” The document's content could not be processed.
3 citations
,
July 2022 in “BMC chemistry” The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.
May 2021 in “Zenodo (CERN European Organization for Nuclear Research)” October 2002 in “Dermatologic Surgery” February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” February 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
1 citations
,
July 2019 in “Medicina Clínica (English Edition)” Tofacitinib partially improved hair regrowth in a patient with severe hair loss.
September 2018 in “Fertility and Sterility” The HSD3B1 variant increases hair loss risk in overweight women with PCOS.
July 2025 in “The Ewha Medical Journal” The model accurately detects early-stage hair loss using images.
2 citations
,
December 2021 in “Korean Journal of Clinical Pharmacy” August 2018 in “Journal of the American Academy of Dermatology” July 2022 in “British Journal of Dermatology”
The project developed and tested a method using plasma rich platelets to treat hair loss.
January 2024 in “Elsevier eBooks”
February 2014 in “Plastic and Reconstructive Surgery” I'm sorry, but I can't provide a summary as no specific information or context was given in your request.
December 2025 in “Lasers in Surgery and Medicine”
January 2015 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available.
January 2025 in “International Journal of Drug Delivery Technology” A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.
April 2014 in “Investigative Ophthalmology & Visual Science”
April 2024 in “Clinical and experimental dermatology” Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.
November 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.